New NCI Educational Resources Help Patients Understand Chemotherapy and Manage Side Effects

NCI is excited to announce a new series of educational resources designed to help patients understand chemotherapy and manage its side effects. Written for patients and health care providers, this series includes:

The easy-to-read fact sheets are research-based and have been pilot-tested in cancer centers across the U.S. They provide clear steps to help patients prevent or manage side effects, understand what chemotherapy is, and how it is given. Check out the booklet for providers to see tips on how to use these fact sheets to increase patient comprehension and adherence.

The attached flyer has more information for you, and for you to share with interested colleagues.

For FREE Copies of These Resources: Call NCI's Cancer Information Service at 1-800-422-6237 (1-800-4-CANCER) or Order from NCI's Publications Locator

ESA Update

The Centers for Medicare and Medicaid Services is seeking public comment on their proposed determination that there is sufficient evidence to conclude that erythropoiesis stimulating agent (ESA) treatment is not reasonable and necessary for beneficiaries with certain clinical conditions, either because of a deleterious effect of the ESA on their underlying disease or because the underlying disease increases their risk of adverse effects related to ESA use. Click here to read more of CMS proposed decision.

ONS Response to CMS Proposed Decision

US Food and Drug Administration Health Advisory

Commentary on the CMS Proposed Ruling from Other Organizations

  • National Comprehensive Cancer Network: Cancer and Treatment Related Anemia
  • American Society of Hematology: Statement on Medicare Proposed National Coverage Policy on Erythropoiesis-Stimulating Agents
  • American Society of Clinical Oncology: Proposed National Coverage Policy on Erythropoiesis Stimulating Agents